A novel seizure quality index based on ictal parameters for optimizing clinical decision-making in electroconvulsive therapy. Part 2: Validation
- 90 Downloads
Early identification of patients who are at a high risk for an unfavorable outcome to ECT during the treatment course might be beneficial because it provides an opportunity for timely intensification or optimization of stimulus conditions. We aimed to validate a previously developed seizure quality index (SQI) that delivers a clinically relevant outcome prediction early in the treatment course and can be used within common clinical setting. Therefore, a prospective study was conducted. Patients (n = 26) below the age of 65 years with a depressive episode and the clinical decision for ECT (right unilateral, brief pulse) were included and several ictal parameters, the SQI for non-response and non-remission, and the clinical outcome of the patients were documented. Logistic regression analysis revealed a statistically significant association between the SQI and non-response (p = 0.035). A significant association between the clinical outcome of non-response and the classified outcome of non-response was detected (p = 0.041). The overall classification accuracy regarding response/non-response was 71.3%, and the model revealed a sensitivity of 84.6% and a specificity of 61.5% for non-response. In this study, we could validate the SQI for the clinical outcome of non-response, but not for non-remission. Based on our data, the SQI might become an interesting clinical tool for early outcome prediction for ECT in patients with depression.
KeywordsElectroconvulsive therapy Depression Outcome Prediction
LK received support by the German Research Foundation (DFG—Grant no. KR 4689/3-1).
Compliance with ethical standards
Conflict of interest
All authors declare that they have no conflict of interest.
- 1.Abrams R (2002) Electroconvulsive therapy. Oxford University Press, OxfordGoogle Scholar
- 2.American Psychiatric Association (2001) The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging (a task force report of the American Psychiatric Association). American Psychiatric Association, Washington, DCGoogle Scholar
- 4.Fink M (2009) Electroconvulsive therapy—a guide for professionals and their patients. Oxford University Press, New YorkGoogle Scholar
- 7.Ghaleiha A, Davari H, Jahangard L, Haghighi M, Ahmadpanah M, Seifrabie MA, Bajoghli H, Holsboer-Trachsler E, Brand S (2016) Adjuvant thiamine improved standard treatment in patients with major depressive disorder: results from a randomized, double-blind, and placebo-controlled clinical trial. Eur Arch Psychiatry Clin Neurosci 266:695–702CrossRefGoogle Scholar
- 8.Gibbons RD, Hur K, Brown CH, Davis JM, Mann JJ (2012) Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Arch Gen Psychiatry 69:572–579Google Scholar
- 17.Mankad MV, Beyer JL, Weiner RD, Krystal AD (2010) Clinical manual of electroconvulsive therapy. American Psychiatric Publishing, Washington, DCGoogle Scholar
- 19.McCall WV (2013) Is remission a necessary and sufficient definition of success in electroconvulsive therapy? Part 1. J ECT 29:257Google Scholar